Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.21 | 4e-06 |
mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 4e-05 |
mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.21 | 8e-05 |
mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.19 | 9e-05 |
mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.18 | 0.0003 |
mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |
mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |
mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.098 | 0.0009 |